Kathryn Dzintars

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression”.

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression

Clinical Infectious Diseases(2021)10.1093/cid/ciab888

N/A

0DataRank · unranked

115 citations

Heba H. Mostafa, Yehudit Bergman, Michael Ante, Tsigereda Tekle, Ayomikun Adebayo +4 more

Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia

Clinical Infectious Diseases(2023)10.1093/cid/ciad009

N/A

0DataRank · unranked

49 citations

Jae Hyoung Lee, Sara E. Cosgrove, Kathryn Dzintars, Suiyini Fiawoo, Emily L. Heil +7 more

Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00907-24

N/A

0DataRank · unranked

28 citations

Sara E. Cosgrove, Robert A. Bonomo, Kathryn Dzintars, Sara M. Karaba, Armani M. Hawes +4 more